Trial intelligence / Profile preview

Idebenone in Patients With Carotid Plaque and Moderate Stenosis

ChiCTR2100049611Phase 4Recruiting

Sponsor
Qilu Hospital of Shandong University
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Ischaemic cerebral disease and Carotid artery disease (CAD) comparing Idebenone with Placebo (2 arms). Primary endpoint: Carotid plaque volume. Started Jan 2021; status: recruiting.

02

Drugs

idebenone
03

Conditions

Ischaemic cerebral diseaseCarotid artery disease (CAD)

Beyond the preview

Go deeper on ChiCTR2100049611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call